Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy
Nanoscale · 2025
DOI: 10.1039/d4nr04557b ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Gui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Glioblastoma, Paclitaxel, Brain Neoplasms. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Through transcriptomic analysis of glioblastoma tissues from patients, we developed a combined formulation (NanoAid) for improving glioma synergistic chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China.
- National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Labo…
- Medical College of Guangxi University, Nanning 530004, China.
- Department of Anaesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 211101, China. hongguang_bao@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, G., Xu, Y., Zhou, A., Yu, Y., Ning, X., & Bao, H. (2025). Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy. Nanoscale. https://doi.org/10.1039/d4nr04557b
Vancouver
Zhang G, Xu Y, Zhou A, Yu Y, Ning X, Bao H. Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy. Nanoscale. 2025. doi:10.1039/d4nr04557b
BibTeX
@article{Zhang2025,
author = {Zhang, Gui and Xu, Yurui and Zhou, Anwei and Yu, Yongle and Ning, Xinghai and Bao, Hongguang},
title = {Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr04557b}
}
EUVIMED